Recovery of a Patient from Clinical Rabies --- Wisconsin, 2004
Rabies is a viral infection of the central nervous system, usually contracted
from the bite of an infected animal, and is nearly always fatal without
proper postexposure prophylaxis (PEP) (1). In October 2004, a previously healthy
female aged 15 years in Fond du Lac County, Wisconsin, received a diagnosis of
rabies after being bitten by a bat approximately 1 month before symptom onset.
This report summarizes the investigation conducted by the Wisconsin Division
of Public Health (WDPH), the public health response in Fond du Lac County, and
the patient's clinical course through December 17. This is the first
documented recovery from clinical rabies by a patient who had not received either pre-
or postexposure prophylaxis for rabies.
While attending a church service in September, the girl picked up a bat after
she saw it fall to the floor. She released the bat outside the building; it
was not captured for rabies testing, and no one else touched the bat. While
handling the bat, she was bitten on her left index finger. The wound was
approximately 5 mm in length with some blood present at the margins; it was cleaned
with hydrogen peroxide. Medical attention was not sought, and rabies PEP was not
administered.
Approximately 1 month after the bat bite, the girl complained of fatigue and
tingling and numbness of the left hand. These symptoms persisted, and 2 days
later she felt unsteady and developed diplopia (i.e., double vision). On the
third day of illness, with continued diplopia and onset of nausea and vomiting,
she was examined by her pediatrician and referred to a neurologist. At that
time, the patient continued to have blurred vision and also had partial
bilateral sixth-nerve palsy. Magnetic resonance imaging (MRI) with and without
contrast and magnetic resonance angiography (MRA) studies of her brain were normal,
and the patient was sent home.
On the fourth day of illness, the patient's symptoms continued, and she was
admitted to a local hospital for lumbar puncture and supportive care. On
admission, she was afebrile, alert, and able to follow commands. She had partial
sixth-nerve palsy, blurred vision, and unsteady gait. Standard precautions for
infection control were observed. Lumbar puncture revealed a white blood cell
count of 23 cells/µL (normal: 0 cells/µL) with 93% lymphocytes, a red blood cell
count of 3 cells/µL (normal: 0 cells/µL), a protein concentration of 50 mg/dL
(normal: 15--45 mg/dL), and a glucose concentration of 58 mg/dL (normal:
40--70 mg/dL). During the next 36 hours, she had slurred speech, nystagmus, tremors
of the left arm, increased lethargy, and a temperature of 102oF (38.9oC).
On the sixth day of illness, the bat-bite history was reported, and rabies
was considered in the differential diagnosis. The patient was transferred to a
tertiary care hospital. Because rabies was recognized as a possibility,
expanded infection-control measures, including droplet precautions and one-to-one
nursing, were instituted at time of transport. On arrival, the patient had a
temperature of 100.9oF (38.3oC), impaired muscular coordination, difficulty
speaking, double vision, muscular twitching, and tremors in the left arm. She was
somewhat obtunded but answered questions appropriately and complied with
commands.
Blood serum, cerebrospinal fluid (CSF), nuchal skin samples, and saliva were
submitted to CDC for rabies testing. MRI with and without contrast and
angiogram/venogram sequences were normal. She had hypersalivation and was intubated.
Rabies-virus--specific antibodies were detected in the patient's serum and
CSF. Direct fluorescent antibody staining of nuchal skin biopsies was negative
for viral antigen, and rabies virus was not isolated from saliva by cell
culture. Rabies-virus RNA was not detectable by reverse transcriptase polymerase
chain reaction assay of either sample. Therefore, identification of the virus
variant responsible for this infection was not possible.
Clinical management of the patient consisted of supportive care and
neuroprotective measures, including a drug-induced coma and ventilator support.
Intravenous ribavirin was used under an investigational protocol. The patient was
kept comatose for 7 days; during that period, results from lumbar puncture
indicated an increase in antirabies IgG by immunofluorescent assay from 1:32 to
1:2,048. Her coma medications were tapered, and the patient became increasingly
alert. On the 33rd day of illness, she was extubated; 3 days later she was
transferred to a rehabilitation unit. At the time of transfer, she was unable to
speak after prolonged intubation. As of December 17, the patient remained
hospitalized with steady improvement. She was able to walk with assistance, ride a
stationary cycle for 8 minutes, and feed herself a soft, solid diet. She solved
math puzzles, used sign language, and was regaining the ability to speak. The
prognosis for her full recovery is unknown.
To provide community members accurate information about rabies and its
transmission, local and state health officials held a press conference on October
21. Public health officials and community pediatricians visited the patient's
school to assess the need for rabies prophylaxis among students. WDPH
distributed assessment tools to the local health department to screen health-care
workers and community contacts of the patient for exposure to potentially infectious
secretions. The patient's five family members, five of 35 health-care
workers, and 27 of 55 community contacts received rabies PEP, either because of
exposure to the patient's saliva during sharing of beverages or food items or after
contact with vomitus. No health-care workers at the tertiary care hospital
required PEP. Site inspection of the church revealed no ongoing risk for
exposure to bats.
Reported by: RE Willoughby, MD, MM Rotar, Children's Hospital
|